Market Research Logo

Global Biologics Manufacturing Market 2018-2022

Global Biologics Manufacturing Market 2018-2022

About Biologics

Biologics, biopharmaceutical, biologic drugs, or biological drugs refer to drugs that are extracted, synthesized, and manufactured from biological material derived from living sources, such as humans, plants, and animals. Biologics manufacturing refers to the production of such drugs.

Technavio’s analysts forecast the Global Biologics Manufacturing Market to grow at a CAGR of 9.11% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the biologics manufacturing market. To calculate the market size, the report considers the cost incurred for in-house manufacturing of biologics and the revenue generated by contract manufacturers of biologics across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, biologics manufacturing market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Amgen
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Merck & Co
  • Pfizer
Market driver
  • Introduction of new biologic drugs for treating diseases
  • For a full, detailed list, view our report
Market challenge
  • High cost of branded drugs is deterring market growth
  • For a full, detailed list, view our report
Market trend
  • Rise in partnerships between traditional biopharma companies and biotechnology startups
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


  • Executive summary
  • Scope of the report
  • Research methodology
  • Market landscape
    • Market ecosystem
      • Table Related market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2017
      • Table Market size 2017
      • Table Validation techniques employed for market sizing 2017
    • Market size and forecast 2017-2022
      • Table Global – Market size and forecast 2017-2022 ($ bn)
      • Table Global – Year-over-year growth 2018-2022 (%)
  • Five forces analysis
    • Table Five forces analysis 2017
    • Table Five forces analysis 2022
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2017
  • Market segmentation by technology
    • Segmentation by technology
      • Table Technology – Market share 2017-2022 (%)
    • Comparison by technology
      • Table Comparison by technology
    • In-house – Market size and forecast 2017-2022
      • Table In-house – Market size and forecast 2017-2022 ($ bn)
      • Table In-house – Year-over-year growth 2018-2022 (%)
    • Outsourced – Market size and forecast 2017-2022
      • Table Outsourced – Market size and forecast 2017-2022 ($ bn)
      • Table Outsourced – Year-over-year growth 2018-2022 (%)
    • Market opportunity by technology
      • Table Market opportunity by technology
  • Market segmentation by product
    • Segmentation by product
      • Table Product – Market share 2017-2022 (%)
    • Comparison by product
      • Table Comparison by product
    • Biologics – Market size and forecast 2017-2022
      • Table Biologics – Market size and forecast 2017-2022 ($ bn)
      • Table Biologics – Year-over-year growth 2018-2022 (%)
    • Biosimilars – Market size and forecast 2017-2022
      • Table Biosimilars – Market size and forecast 2017-2022 ($ bn)
      • Table Biosimilars – Year-over-year growth 2018-2022 (%)
    • Market opportunity by product
      • Table Market opportunity by product
  • Customer landscape
    • Table Customer landscape
  • Regional landscape
    • Geographical segmentation
      • Table Global – Market share by geography 2017-2022 (%)
    • Regional comparison
      • Table Regional comparison
    • Americas – Market size and forecast 2017-2022
      • Table Americas – Market size and forecast 2017-2022 ($ bn)
      • Table Americas – Year-over-year growth 2018-2022 (%)
    • EMEA – Market size and forecast 2017-2022
      • Table EMEA – Market size and forecast 2017-2022 ($ bn)
      • Table EMEA – Year-over-year growth 2018-2022 (%)
    • APAC – Market size and forecast 2017-2022
      • Table APAC – Market size and forecast 2017-2022 ($ bn)
      • Table APAC – Year-over-year growth 2018-2022 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Rise in partnerships between traditional biopharma companies and biotechnology startups
    • Growing outsourcing of biologics manufacturing
    • Increase in FDA approvals for new biologics products
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Amgen
      • Table Amgen: Overview
      • Table Amgen – Business segments
      • Table Amgen – Organizational developments
      • Table Amgen – Geographic focus
      • Table Amgen – Key offerings
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Overview
      • Table F. Hoffmann-La Roche– Business segments
      • Table F. Hoffmann-La Roche – Organizational developments
      • Table F. Hoffmann-La Roche– Geographic focus
      • Table F. Hoffmann-La Roche– Segment focus
      • Table F. Hoffmann-La Roche – Key offerings
    • Johnson & Johnson
      • Table Johnson & Johnson: Overview
      • Table Johnson & Johnson– Business segments
      • Table Johnson & Johnson – Organizational developments
      • Table Johnson & Johnson – Geographic focus
      • Table Johnson & Johnson – Segment focus
      • Table Johnson & Johnson – Key offerings
    • Merck & Co.
      • Table Merck & Co.: Overview
      • Table Merck & Co. – Business segments
      • Table Merck & Co. – Organizational developments
      • Table Merck & Co. – Geographic focus
      • Table Merck & Co. – Segment focus
      • Table Merck & Co. – Key offerings
    • Pfizer
      • Table Pfizer: Overview
      • Table Pfizer – Business segments
      • Table Pfizer – Organizational developments
      • Table Pfizer – Geographic focus
      • Table Pfizer – Segment focus
      • Table Pfizer – Key offerings
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report